Interleukin Collaborates with Isis Pharmaceuticals for Genetic Testing Services
Under a new agreement, Interleukin Genetics will provide genetic profiling for a clinical trial evaluating Isis-APO(a)Rx for patients with high lipoprotein(a).
Read MorePosted by Steve Halasey | Jan 12, 2015 | Research |
Under a new agreement, Interleukin Genetics will provide genetic profiling for a clinical trial evaluating Isis-APO(a)Rx for patients with high lipoprotein(a).
Read MorePosted by Jenny Lower | Jan 12, 2015 | Clinical Chemistry |
Beckman Coulter Diagnostics has received FDA clearance for its Access 25(OH) Vitamin D Total assay, which comes with innovative packaging designed to prevent light-induced reagent degradation.
Read MorePosted by Jenny Lower | Jan 7, 2015 | Cancer, Molecular Diagnostics |
Advances in whole-genome sequencing technology such as copy-number assays are driving significant progress in the diagnosis and treatment of cancer.
Read MorePosted by Steve Halasey | Dec 30, 2014 | Compliance, Infectious Diseases, Sexually Transmitted Diseases |
FDA’s action will permit the Syphilis Health Check test to be used by untrained healthcare workers in a variety of nontraditional settings.
Read MorePosted by Jenny Lower | Dec 29, 2014 | Flu & Respiratory Infections, Infectious Diseases |
The Simplexa Flu A/B & RSV Direct kit from Focus Diagnostics, Cypress, Calif, has received FDA clearance for eight additional influenza strains, including H3N2v and the novel avian influenza A strain H7N9.
Read More